Editing Natural therapeutics
The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then publish the changes below to finish undoing the edit.
Latest revision | Your text | ||
Line 214: | Line 214: | ||
In 2018 [[w:Insys Therapeutics|Insys Therapeutics]] announced the the [[w:Food and Drug Administration|FDA]] has given CBD an [[w:orphan drug|orphan drug]] designation (ODD) to CBD for treating gliomas.<ref name="WPHealth2018glioma">http://wphealth.cc/2018/10/11/fda-approves-cannabis-for-brain-cancer-treatment/</ref> | In 2018 [[w:Insys Therapeutics|Insys Therapeutics]] announced the the [[w:Food and Drug Administration|FDA]] has given CBD an [[w:orphan drug|orphan drug]] designation (ODD) to CBD for treating gliomas.<ref name="WPHealth2018glioma">http://wphealth.cc/2018/10/11/fda-approves-cannabis-for-brain-cancer-treatment/</ref> | ||
* [https://www.calgarycmmc.com/cancerglioma.htm Extensive compendium of research about brain cancer and cannabis at calgarycmmc.com] | * [https://www.calgarycmmc.com/cancerglioma.htm Extensive compendium of research about brain cancer and cannabis at calgarycmmc.com] | ||
* https://herb.co/news/health/cannabis-treat-brain-cancer/ | * https://herb.co/news/health/cannabis-treat-brain-cancer/ |